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Dear Sir,
I would like to address the earlier Letter to the Editor
‘The pathophysiological significance of red blood cell
nitric oxide concentrations in inflammatory Behc ¸et’s
disease’ by Everklioglu et al.i nMediators of Inflam-
mation.
1 It is not hard to accept that NO production
is enhanced in active inflammation in Behc ¸et’s
disease, and this may be reflected in the elevation
of end-products (NO2
  and NO3
 :N O x) in circulating
blood as is supported by some other groups. How-
ever, in the article, elevation of NOx in red blood cells
(RBCs) in patients with Behc ¸et’s disease is reported. I
would like to ask the authors about the following
points:
1. How NOx contamination was eliminated
from every experimental procedure.
2. How hemoglobin was removed from hemo-
lysate before the Griess reaction.
The first was very important to quantify NOx, because
NOx contamination in laboratory ware
2 sometimes
makes accurate evaluation of NOx difficult. In addi-
tion, NOx contamination in water
3 used for buffer
preparation could be a cause of fatal error.
In our experience, NO3
  easily passes the mem-
brane of RBCs bi-directionally through an anion
exchanger. The rate of the influx or efflux of NO3
 
is very rapid and equilibrium (ratio of NOx concen-
tration of intra-RBCs to extra-RBCs around 0.8) is
established within 2 min.
4 This means that when
RBCs were washed with a buffer containing NOx, the
NOx level in RBCs would become similar to that of
the buffer. When the NOx level in the buffer is near
zero, only a scar level of NOx is recognized in RBCs.
4
However, the NOx content reported in the Letter to
the Editor is rather high (when hemoglobin and
hematocrit are set at 15 g/dl and 45%, respectively,
the RBC NOx level in the control subjects is calculated
to be about 43 mM). This may indicate NOx contam-
ination of the buffer used to wash RBCs, or a new
finding that the anion exchanger in RBCs in Behc ¸et’s
disease is impaired, in that NOx was retained within
RBCs. If the latter is the case, it would be worthwhile
to examine the rate of influx and efflux of NOx
through an anion exchanger.
The second question also concerns the NOx
contamination. Because hemoglobin interferes with
absorption at 540 nm, it is inevitable to remove the
substance before colorimetric measurement. For this
sake, ultrafiltration is commonly used. However, the
membrane of the unit is heavily contaminated with
NOx without exception.
3 This may also be a cause of
high NOx contents in RBCs in both patients and
control subjects.
I hope the authors took particular care of these
points, and the difference in RBC
NOx level between the patients and the control
subjects did not rest on a large number of chance
events.
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Dear Sir,
We thank Dr Ishibashi for his important contributions
on our previous paper.
1 Because our published paper
was a Letter to the Editor, the study protocol was not
stated in detail. All stock and working solutions were
prepared with double-distilled and deionized water
(NOxB/1 mmol). After obtaining fasting whole-blood
samples from all subjects, hematocrit and hemoglo-
bin analyses were performed. After the centrifugation
at 3000 /g for 10 min, the plasma and buffy coat
were carefully discarded and the RBC pellet was
subsequently washed three times with isotonic (295
mOsM) NaCl phosphate buffer containing 150 mM
NaCl, 1.9 mM NaH2PO4, 8.1 mM Na2HPO4 (pH 7.4).
All laboratory ware (polypropylene disposable
tips, vacuum blood sampling tubes, centrifuge tubes,
conical tubes and other glassware) were washed
three times (for 5 min) in large containers with pure
water before use to minimize NOx contamination.
Therefore, we do not expect any contamination
during the procedure of our experimental process.
In addition, NOx concentrations were also measured
in two samples of pure water as it was for the patients
and control subjects. If an excess contamination
occurred (NOx /2 mmol/l), we repeated the experi-
ment.
Because we deproteinized the hemolysate and
studied with a transparent supernatant, there will
not be hemoglobin (Hb) interference at 540 nm. In
addition, we would like to correct the calculated
values of Ishibashi (when Hb and hematocrit are set
at 15 g/dl and 45%, respectively, the RBC NOx level in
the control subjects is calculated to be about 43 mmol/
l) as follows; control Hb /14.1 g/dl, HbNOx /18.29
mmol/l and hematocrit /43.1%. Control NOx:Hb /
18.29 mmol/l:14.1 g/dl /0.12971 mmol/g Hb (129.7
nmol/gHb). This means that whole blood RBC
HbNO levels in control subjects were 18.29 mM.
This value is about one-third of the plasma levels
found in our previous paper.
2
NO can be found in RBC in various forms including
(HbFe
2 NO, NO
+, HbFe
3 NO2, HbFe
IIIOONO,
NO2
 ,N O 3
  SNO-Hb, etc.). Therefore, although there
may be equilibrium after washing with the buffer, NO
that is bound to Hb will still be in the RBCs.
One reason for the increased RBC NO levels found
in our study may be the drugs that the patients used
(not stated in the paper). All patients in our study
were under the treatment of steroids, colchicines and
immunosuppressives. It is therefore possible that
these agents may prevent NO3
  transport through
the anion exchanger. As a result, it is open to further
study whether these agents could modify NO3
 
transport across the RBC membrane via the anion
exchanger. Another hypothesis may be that the anion
exchanger may be impaired in patients with Behc ¸et’s
disease, which also awaits further investigation.
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